Report Indicates Midwest Biotechs Buck Nationwide Decline in Q1 VC Financing
May 01, 2009
Report Indicates Midwest Biotechs Buck Nationwide Decline in Q1 VC Financing
BioEnterprise's Midwest Health Care Venture Investment Report showed a total 47 companies raising a combined $155.6 million during the first quarter of 2009, compared with 14 companies winning $133.5 million in the year-ago period.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Pharmas Nudge Semantic Web Technology Toward Practical Drug Discovery Applications
March 6, 2009 / BioInform - Around the Regions
February 2, 2009 / - Study Suggests Two-Gene Combo Predicts Spectrum of Response to ARCA's Beta Blocker Gencaro
October 24, 2012 / Pharmacogenomics Reporter - Astute Medical Completes $40M Series C Funding Round
June 8, 2012 / ProteoMonitor - FDA Looks into Pradaxa Bleeding Risk; What Does it Mean for PGx-Guided Warfarin Dosing?
December 14, 2011 / Pharmacogenomics Reporter